Codes / ICD10CM / L40.3

L40.3 Pustulosis palmaris et plantaris

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Pustulosis Palmaris et Plantaris
  • A chronic inflammatory skin condition affecting the palms and soles, characterized by pustular eruptions.

Summary

Pustulosis palmaris et plantaris is a localized form of pustular psoriasis that primarily involves the palms of the hands and soles of the feet. It is marked by recurrent pustules, erythema, and scaling, often leading to discomfort and functional impairment. The condition is chronic and may persist for years, with periods of flare-ups and remission.

Causes

The exact cause is not fully understood, but it is associated with dysregulated immune responses and genetic predisposition. Triggers may include trauma to the affected areas, infections, or underlying systemic conditions. Autoimmune mechanisms are thought to drive the persistent inflammation and pustule formation.

Risk Factors

  • Genetic predisposition: Family history of psoriasis or pustular variants.
  • Trauma: Physical injury to the palms or soles may precipitate or worsen lesions.
  • Infections: Bacterial or viral infections may act as triggers.
  • Underlying psoriasis: Pre-existing plaque psoriasis increases susceptibility.

Symptoms

  • Pustules on the palms or soles.
  • Erythema and scaling of the affected skin.
  • Pain, burning, or itching.
  • Thickened, cracked skin that may bleed.
  • Nail changes, such as pitting or onycholysis, if the condition extends to the nail beds.

Diagnosis

Diagnosis is typically based on clinical evaluation, including a physical examination of the palms and soles. A skin biopsy may be performed to confirm the presence of pustules and rule out other conditions. Laboratory tests, such as blood work, may be used to assess for underlying triggers or associated conditions.

Treatment Options

Treatment focuses on managing symptoms and reducing inflammation. Topical therapies, such as corticosteroids or calcipotriene, are often first-line. For more severe cases, systemic medications like methotrexate or biologics may be prescribed. Phototherapy and retinoids are also used in some instances.

Prognosis and Follow-Up

The condition is chronic and may require long-term management. Flare-ups can be unpredictable, but treatment can help control symptoms. Regular follow-up with a healthcare provider is important to monitor for complications and adjust therapy as needed.

Complications

  • Secondary bacterial infections from broken skin.
  • Permanent nail damage or loss if the condition affects the nail beds.
  • Functional impairment due to pain or thickened skin.

Lifestyle & Prevention

  • Avoid trauma to the palms and soles.
  • Keep the skin moisturized to reduce cracking.
  • Manage stress, as it may trigger flare-ups.
  • Follow prescribed treatment plans consistently.

When to Seek Professional Help

Seek medical attention if symptoms worsen, new pustules appear, or signs of infection (e.g., increased redness, pus, fever) develop. Prompt evaluation is important for severe or persistent cases.

Tips for Medical Coders

When coding for pustulosis palmaris et plantaris (L40.3), ensure documentation supports the localized nature of the condition affecting the palms and soles. Note the presence of pustules, erythema, and scaling, as well as any associated nail changes or triggers. Verify that the diagnosis aligns with clinical findings to support accurate coding.

Medical Policies and Guidelines

Related policies from health plans

Stelara (ustekinumab)
Book a walkthrough

L40.3 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.